What are the current odds for "FDA approves Retatrutide this year?"?

As of March 2026, prediction markets give this a 23.0% probability of resolving Yes. This market is trading on Polymarket with $543.5K in total volume.

Where can I trade on "FDA approves Retatrutide this year?"?

This market is available on Polymarket. You can trade Yes shares at 23.0% or No shares at 77.0%. The market has $6.6K in liquidity.

When does this prediction market close?

This market is scheduled to resolve 9 months (Dec 31, 2026). After resolution, winning shares pay out $1.00 each.

Polymarketother

FDA approves Retatrutide this year?

Updated Today

Retatrutide represents the next frontier in weight-loss pharmaceuticals, competing with blockbusters like Ozempic. Markets currently give FDA approval this year just a 23% chance, suggesting skepticism about meeting the tight regulatory timeline.

Current Probability

23.0%+0.05%24h

Trade on Polymarket

YesNo

If Yes wins

$4.35 return per $1

If No wins

$1.30 return per $1